✦ LIBER ✦

High risk patients with pulmonary metastases of renal cell carcinoma: Safety and efficacy of inhaled interleukin-2 (IL-2) compared to systemic IL-2

✍ Scribed by E. Huland; H. Heinzer; H. Huland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival analysis in patients with pulmo

✍ H. Heinzer; M. Toma; E. Huland; H. Huland 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Enhanced survival of IFN-α augmented IL-

✍ Benjamin Kim; Patricia Warnaka 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 816 KB

Immunotherapy with interleukin-2 (IL2) a

✍ Escudier, B; Farace, F; Angevin, E; Charpentier, F; Nitenberg, G; Triebel, F; He 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 780 KB

470 Original regimen of subcutaneous int

✍ B. Escudier; J.F. Rossi; A. Ravaud; J. Savary; K. Pignard; S. Négrier 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The use of polyethylene glycol-modified

✍ James C. Yang; Suzanne L. Topalian; Douglas J. Schwartzentruber; David R. Parkin 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

The High-Dose Aldesleukin (IL-2) “Select

✍ Jessica M. Clement; David F. McDermott 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB